Hyperglycemia from olanzapine treatment in adolescents.

Abstract:

:The increasing use of olanzapine for treating adolescent patients has brought with it greater awareness of the recognized side effects of this medication, especially weight gain. Of the reports of glucose dysregulation related to olanzapine therapy, only a few pertain to adolescents. We present five cases: two youths who consequently suffered from overt diabetes and three who responded with glucose dysregulation. According to the Naranjo probability scale, the relation of this phenomenon to olanzapine therapy is "probable." We consider the findings of the presented case series as justification for regular metabolic follow-up for apparently healthy adolescents receiving olanzapine therapy.

authors

Bloch Y,Vardi O,Mendlovic S,Levkovitz Y,Gothelf D,Ratzoni G

doi

10.1089/104454603321666234

keywords:

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

97-102

issue

1

eissn

1044-5463

issn

1557-8992

journal_volume

13

pub_type

杂志文章
  • Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project.

    abstract:OBJECTIVE:Little is known about the pattern of service receipt and outcomes from clinics implementing best practice guidelines in child mental health. This study aimed to determine these variables for a clinic that implemented an attention-deficit/hyperactivity disorder (ADHD) treatment guideline proposed by the Childr...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2014.0014

    authors: Wagner DJ,Vallerand IA,McLennan JD

    更新日期:2014-11-01 00:00:00

  • Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.

    abstract::The prevalence and treatment of behavioral and mental illnesses in the adolescent population are increasing, and many of the medications used are continued into adulthood. Increased vigilance is necessary when caring for this population to prevent side effects and drug interactions. In this short communication, we pre...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2005.15.693

    authors: George AK,Kunwar AR,Awasthi A

    更新日期:2005-08-01 00:00:00

  • A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder.

    abstract:OBJECTIVE:This functional magnetic resonance imaging (fMRI) study investigated the effects of pharmacotherapy on brain function underlying affect dysregulation and cognitive function in pediatric bipolar disorder (PBD). METHOD:Healthy controls (HC) (n=14; mean age =14.1 ± 2.4 years) and unmedicated PBD patients with m...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2009.0105

    authors: Pavuluri MN,Passarotti AM,Parnes SA,Fitzgerald JM,Sweeney JA

    更新日期:2010-10-01 00:00:00

  • Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.

    abstract:OBJECTIVES:The aim of this study is to identify predictors of pill placebo response and to characterize the temporal course of pill placebo response in anxious youth. METHODS:Data from placebo-treated patients (N = 76) in the Child/Adolescent Anxiety Multimodal Study (CAMS), a multisite, randomized controlled trial th...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1089/cap.2016.0198

    authors: Strawn JR,Dobson ET,Mills JA,Cornwall GJ,Sakolsky D,Birmaher B,Compton SN,Piacentini J,McCracken JT,Ginsburg GS,Kendall PC,Walkup JT,Albano AM,Rynn MA

    更新日期:2017-08-01 00:00:00

  • Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.

    abstract:OBJECTIVE:The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. METHOD:Thirty-six medication-naïve children ages 9-14 years diagnosed with attention-deficit/hyperactivity disorder (ADHD) were enrolled for 6 weeks in a crossover trial,...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2012.0085

    authors: Ramtvedt BE,Røinås E,Aabech HS,Sundet KS

    更新日期:2013-11-01 00:00:00

  • A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder Treatment.

    abstract:OBJECTIVE:Different methylphenidate (MPH) formulations, immediate release (IR) or extended release (ER), have been developed to treat Attention-Deficit/Hyperactivity Disorder (ADHD). A better use of these formulations, with a proper choice of their timing, dosage, and combination, can help to attain optimal therapeutic...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2018.0093

    authors: Soufsaf S,Robaey P,Bonnefois G,Nekka F,Li J

    更新日期:2019-04-01 00:00:00

  • Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children.

    abstract:: Objective: We aimed to (1) examine differences in observed visual attention and motor activity, as well as comprehension of a science video between children with and without attention-deficit/hyperactivity disorder (ADHD) and (2) explore if psychostimulant medication impro...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2018.0006

    authors: Orban SA,Karamchandani TA,Tamm L,Sidol CA,Peugh J,Froehlich TE,Brinkman WB,Estell N,Mii AE,Epstein JN

    更新日期:2018-12-01 00:00:00

  • A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.

    abstract::Although sensory deficits are frequently observed in autistic individuals, pharmacologic interventions targeting these abnormalities are lacking. The goal of this investigation was to assess the effectiveness of aripiprazole in targeting sensory deficits in children and adolescents with autism. Using an outpatient cli...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2010.0103

    authors: Fung LK,Chahal L,Libove RA,Bivas R,Hardan AY

    更新日期:2012-06-01 00:00:00

  • Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo.

    abstract::This meta-analysis assessed aggression and/or hostility-related events in children and adolescents treated with fluoxetine (n = 376) compared with placebo (n = 255). Aggression and/or hostility-related events were identified in 2.1% of fluoxetine versus 3.1% of placebo-treated patients (p = 0.588). This analysis fails...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1089/cap.2006.0138

    authors: Tauscher-Wisniewski S,Nilsson M,Caldwell C,Plewes J,Allen AJ

    更新日期:2007-10-01 00:00:00

  • Quetiapine monotherapy in adolescents with bipolar disorder comorbid with conduct disorder.

    abstract::Bipolar Disorders (BD) are often comorbid with disruptive behaviour disorders (DBDs) (oppositional-defiant disorder or conduct disorder), with negative implications on treatment strategy and outcome. The aim of this study was to assess the efficacy of quetiapine monotherapy in adolescents with BD comorbid with conduct...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2013.0063

    authors: Masi G,Pisano S,Pfanner C,Milone A,Manfredi A

    更新日期:2013-10-01 00:00:00

  • Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

    abstract:OBJECTIVE:The purpose of this study was to evaluate the short- and long-term efficacy and safety of ziprasidone in children and adolescents with bipolar I disorder. METHODS:Subjects 10-17 years of age with a manic or mixed episode associated with bipolar I disorder participated in a 4 week, randomized, double-blind, p...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1089/cap.2012.0029

    authors: Findling RL,Cavuş I,Pappadopulos E,Vanderburg DG,Schwartz JH,Gundapaneni BK,DelBello MP

    更新日期:2013-10-01 00:00:00

  • Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.

    abstract:BACKGROUND:Still little is known about neuropsychological differences between boys and girls with attention-deficit/hyperactivity disorder (ADHD) and whether there are sex-specific differences in the modulation of attentional performance by methylphenidate (MPH). METHOD:In this study, 27 males and 27 females between 8...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2009.0060

    authors: Günther T,Herpertz-Dahlmann B,Konrad K

    更新日期:2010-06-01 00:00:00

  • Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder.

    abstract::ABSTRACT The pertinent literature was reviewed on cardiovascular changes induced by psychostimulant medication treatment of hyperactive children. An assessment of 15 controlled studies using test doses of methylphenidate revealed a significant elevation of the resting heart rate in previously unmedicated children (mea...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.1992.2.279

    authors: Safer DJ

    更新日期:1992-01-01 00:00:00

  • An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia.

    abstract::This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and th...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1089/cap.2000.10.103

    authors: Nobile M,Bellotti B,Marino C,Molteni M,Battaglia M

    更新日期:2000-07-01 00:00:00

  • A review of developmental aspects of cytochrome P450.

    abstract::This article surveys the development of human hepatic P450 cytochromes (CYPs) involved in xenobiotic metabolism from the fetus through the life span and explores possible clinical consequences of developmental issues. These hepatic P450 CYPs come "on line" at different times during fetal and infant development, and ea...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,评审

    doi:10.1089/cap.1998.8.161

    authors: Oesterheld JR

    更新日期:1998-01-01 00:00:00

  • Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

    abstract:OBJECTIVE:The aim of this study was to conduct a prospective safety and tolerability study of aripiprazole for the treatment of tics in children and adolescents with Tourette's disorder (TD). METHOD:Eleven subjects (10 males) with TD (age 9-19 years, mean 13.36, standard deviation [SD] 3.33) who did not respond or wer...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1089/cap.2009.0035

    authors: Lyon GJ,Samar S,Jummani R,Hirsch S,Spirgel A,Goldman R,Coffey BJ

    更新日期:2009-12-01 00:00:00

  • Striatal volume abnormalities in treatment-naïve patients diagnosed with pediatric major depressive disorder.

    abstract:OBJECTIVE:The striatum, including the putamen and caudate, plays an important role in executive and emotional processing and may be involved in the pathophysiology of mood disorders. Few studies have examined structural abnormalities of the striatum in pediatric major depressive disorder (MDD) patients. We report stria...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2007.0026

    authors: Matsuo K,Rosenberg DR,Easter PC,MacMaster FP,Chen HH,Nicoletti M,Caetano SC,Hatch JP,Soares JC

    更新日期:2008-04-01 00:00:00

  • Perceived parenting change and child posttraumatic stress following a natural disaster.

    abstract:OBJECTIVE:Recent research suggests that not only parental psychopathology, but also parenting practices, have a role to play in the development of child posttraumatic stress symptoms (PTSS) following a natural disaster. The current study aimed to investigate the relationship between parents' perceptions of their parent...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2013.0051

    authors: Cobham VE,McDermott B

    更新日期:2014-02-01 00:00:00

  • Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder.

    abstract:PURPOSE:The aim of this study was to explore relationships between the Children's Depression Rating Scale-Revised (CDRS-R) and Hamilton Rating Scale for Depression (HAM-D) in adolescent bipolar disorder. We hypothesized that CDRS-R and HAM-D scores would be significantly correlated and both scales would be sensitive to...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2006.16.327

    authors: Patel NC,DelBello MP,Kowatch RA,Strakowski SM

    更新日期:2006-06-01 00:00:00

  • Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

    abstract:OBJECTIVES:This study examines cardiovascular (CV) effects of guanfacine immediate-release (GUAN-IR), dexmethylphenidate extended-release (DMPH), and their combination (COMB) during acute and long-term treatment of youth with attention-deficit/hyperactivity disorder. METHODS:Two hundred seven participants aged 7-14 ye...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2015.0264

    authors: Sayer GR,McGough JJ,Levitt J,Cowen J,Sturm A,Castelo E,McCracken JT

    更新日期:2016-12-01 00:00:00

  • Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.

    abstract:OBJECTIVE:In the four-site Treatment of Severe Childhood Aggression (TOSCA) study, addition of risperidone to stimulant and parent training moderately improved parent-rated disruptive behavior disorder (DBD) symptoms. This secondary study explores outcomes other than DBD and attention-deficit/hyperactivity disorder (AD...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2014.0104

    authors: Arnold LE,Gadow KD,Farmer CA,Findling RL,Bukstein O,Molina BS,Brown NV,Li X,Rundberg-Rivera EV,Bangalore S,Buchan-Page K,Hurt EA,Rice R,McNamara NK,Aman MG

    更新日期:2015-04-01 00:00:00

  • The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).

    abstract:OBJECTIVE:The aim of this study was to compare the efficacy and tolerability of quetiapine and divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorders. METHOD:Patients were included in this post hoc analysis if they scored ...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2006.16.665

    authors: Barzman DH,DelBello MP,Adler CM,Stanford KE,Strakowski SM

    更新日期:2006-12-01 00:00:00

  • Sudden death and tricyclic antidepressants: clinical considerations for children.

    abstract::ABSTRACT The sudden collapse and death in three prepubertal children during routine treatment with desipramine was recently reported in brief statements. Insufficient clinical information is available to infer a cause-and-effect relationship between the therapeutic use of desipramine and sudden death in these children...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.1990.1.125

    authors: Popper CW,Elliott GR

    更新日期:1990-10-01 00:00:00

  • The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome.

    abstract:OBJECTIVE:Methylphenidate (MPH) is commonly used to treat attention-deficit/hyperactivity disorder (ADHD) in all children, including those with velocardiofacial syndrome (VCFS). Yet concerns have been raised regarding its safety and efficacy in VCFS. The goal of this study was to examine the safety and efficacy of MPH ...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/cap.2011.0042

    authors: Green T,Weinberger R,Diamond A,Berant M,Hirschfeld L,Frisch A,Zarchi O,Weizman A,Gothelf D

    更新日期:2011-12-01 00:00:00

  • Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.

    abstract:OBJECTIVE:Guanfacine has been shown to reduce hyperactive behaviors in children with attention-deficit/hyperactivity disorder (ADHD) and possibly in children with pervasive developmental disorder (PDD) and hyperactivity. The aim of this exploratory study was to examine whether gene variants encoding the multidrug resis...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1089/cap.2009.0059

    authors: McCracken JT,Aman MG,McDougle CJ,Tierney E,Shiraga S,Whelan F,Arnold LE,Posey D,Ritz L,Vitiello B,Scahill L

    更新日期:2010-02-01 00:00:00

  • Neuroleptic malignant syndrome: review of experience with children and adolescents.

    abstract::ABSTRACT A report of neuroleptic malignant syndrome (NMS) in an adolescent patient with bipolar disorder is presented, and findings from a literature review of 35 child and adolescent cases (presenting before age 19) are compared with the reported experience in adults. Fever, rigidity, altered mental status, and tachy...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.1992.2.183

    authors: Steingard R,Khan A,Gonzalez A,Herzog DB

    更新日期:1992-10-01 00:00:00

  • Childhood hyperactivity and psychostimulants: a review of extended treatment studies.

    abstract::ABSTRACT Clinical trials with a treatment duration of at least 3 months were reviewed to determine the effect of psychostimulants on the core symptoms of attention-deficit hyperactivity disorder (ADHD) and on its commonly associated features. Eighteen studies were identified: 17 were studies of methylphenidate, 1 was ...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.1993.3.81

    authors: Schachar R,Tannock R

    更新日期:1993-07-01 00:00:00

  • Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.

    abstract::The selective serotonin reuptake inhibitors (SSRIs) are becoming widely used in children and adolescents, with possible unexpected side effects being observed over time. SSRIs have been associated with bleeding in adults who have unremarkable routine hematologic laboratory results except abnormal bleeding time or plat...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2000.10.35

    authors: Lake MB,Birmaher B,Wassick S,Mathos K,Yelovich AK

    更新日期:2000-04-01 00:00:00

  • A prospective, open-label trial of galantamine in autistic disorder.

    abstract:OBJECTIVE:Post-mortem studies have reported abnormalities of the cholinergic system in autism. The purpose of this study was to assess the use of galantamine, an acetylcholinesterase inhibitor and nicotinic receptor modulator, in the treatment of interfering behaviors in children with autism. METHODS:Thirteen medicati...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 杂志文章

    doi:10.1089/cap.2006.16.621

    authors: Nicolson R,Craven-Thuss B,Smith J

    更新日期:2006-10-01 00:00:00

  • A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.

    abstract:OBJECTIVE:The use of methylphenidate (MPH) in the treatment of attention-deficit/hyperactivity disorder (ADHD) is widely accepted; however, there is increased concern regarding its abuse potential. Few studies have examined the reinforcing effects of drugs in individuals receiving them for clinical purposes. This study...

    journal_title:Journal of child and adolescent psychopharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1089/cap.2005.15.729

    authors: MacDonald Fredericks E,Kollins SH

    更新日期:2005-10-01 00:00:00